Last edition
News about "Bristol Myers and Takeda Join AI Consortium to Acc"
Bristol Myers and Takeda Join AI Consortium to Accelerate Drug Discovery
Bristol Myers Squibb and Takeda Pharmaceuticals have agreed to collaborate in a new AI-driven drug discovery initiative, pooling proprietary molecular structure datasets to train an advanced AI model known as OpenFold3.
Bristol Myers And Takeda Join AI Consortium To Acc | 01/10/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members